Incyte (INCY) FCF Margin (2010 - 2026)

Incyte (INCY) reported FCF Margin of 28.22% for Q1 2026, up 325.0% on a YoY basis from 6.64% in Q1 2025, and down 12.97% quarter-over-quarter from 32.43% in Q4 2025.

Incyte (INCY) FCF Margin (2010 - 2026) Analysis & Trends

Incyte has reported FCF Margin for 17 years, with the latest figure at 28.22% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 325.0% year-over-year to 28.22%; the trailing twelve-month figure through Mar 2026 stood at 27.06% (up 1852.0% YoY), and the FY2025 full-year result was 26.35%, up 1850.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 28.22%, down from 32.43% in the prior quarter.
  • The five-year high for FCF Margin was 40.94% in Q3 2025, with the low at 55.18% in Q2 2024.
  • Historically, FCF Margin has averaged 18.8% across 5 years, with a median of 27.08% in 2024.
  • Annual changes were most pronounced in 2024 — FCF Margin tumbled 8652 bps — and 2025, when it surged 5879 bps.
  • Incyte's FCF Margin stood at 36.34% in 2022, then slumped by 69 bps to 11.37% in 2023, then soared by 185 bps to 32.42% in 2024, then gained by 0 bps to 32.43% in 2025, then retreated by 13 bps to 28.22% in 2026.
  • The last three FCF Margin figures came in at 28.22% (Q1 2026), 32.43% (Q4 2025), and 40.94% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 28.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 28.22%
Dec 31, 2025 32.43%
Sep 30, 2025 40.94%
Jun 30, 2025 3.61%
Mar 31, 2025 24.97%
Dec 31, 2024 32.42%
Sep 30, 2024 27.08%
Jun 30, 2024 -55.18%
Mar 31, 2024 24.80%
Dec 31, 2023 11.37%
Sep 30, 2023 18.18%
Jun 30, 2023 31.34%
Mar 31, 2023 -14.53%
Dec 31, 2022 36.34%
Sep 30, 2022 32.62%
Jun 30, 2022 17.68%
Mar 31, 2022 27.27%
Dec 31, 2021 27.21%
Sep 30, 2021 27.42%
Jun 30, 2021 11.31%